HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 182 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,317,157 | -3.0% | 40,194 | +4.2% | 0.00% | 0.0% |
| Q2 2023 | $1,357,595 | +99.8% | 38,579 | +85.4% | 0.00% | 0.0% |
| Q1 2023 | $679,480 | -39.3% | 20,811 | +2.4% | 0.00% | 0.0% |
| Q4 2022 | $1,120,238 | +24.3% | 20,331 | -0.2% | 0.00% | 0.0% |
| Q3 2022 | $901,000 | +2.4% | 20,381 | +12.8% | 0.00% | 0.0% |
| Q2 2022 | $880,000 | +52.5% | 18,062 | +52.3% | 0.00% | – |
| Q1 2022 | $577,000 | +29.1% | 11,858 | +13.0% | 0.00% | – |
| Q4 2021 | $447,000 | +24.5% | 10,491 | +12.0% | 0.00% | – |
| Q3 2021 | $359,000 | +38.1% | 9,370 | +1.7% | 0.00% | – |
| Q2 2021 | $260,000 | – | 9,213 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |